Grifols, S.A. is a global healthcare company focused on plasma-derived therapies, linking plasma collection and industrial processing to produce medicines used in immunology, critical care, and rare diseases.

From donation to medicine

Grifols operates or supports plasma collection and processes plasma through fractionation and manufacturing to produce therapies such as immunoglobulins and albumin. The company also maintains capabilities in diagnostics and biologics adjacent to blood safety and testing.

Manufacturing and compliance

Its operations emphasize controlled cold-chain logistics, validated production, and regulatory compliance across multiple markets. Technical service and supply programs support consistent availability of plasma-derived medicines for hospitals and specialty providers.